Roswell Park Cancer Institute, Buffalo, NY, USA.
Henry Ford Health System, Detroit, MI, USA.
BJU Int. 2020 Aug;126(2):265-272. doi: 10.1111/bju.15083. Epub 2020 May 16.
To compare the perioperative outcomes of intracorporeal (ICUD) vs extracorporeal urinary diversion (ECUD) after robot-assisted radical cystectomy (RARC).
We retrospectively reviewed the prospectively maintained International Robotic Cystectomy Consortium (IRCC) database. A total of 972 patients from 28 institutions who underwent RARC were included. Propensity score matching was used to match patients based on age, gender, body mass index (BMI), American Society of Anesthesiologists Score (ASA) score, Charlson Comorbidity Index (CCI) score, prior radiation and abdominal surgery, receipt of neoadjuvant chemotherapy, and clinical staging. Matched cohorts were compared. Multivariate stepwise logistic and linear regression models were fit to evaluate variables associated with receiving ICUD, operating time, 90-day high-grade complications (Clavien-Dindo Classification Grade ≥III), and 90-day readmissions after RARC.
Utilisation of ICUD increased from 0% in 2005 to 95% in 2018. The ICUD patients had more overall complications (66% vs 58%, P = 0.01) and readmissions (27% vs 17%, P = 0.01), but not high-grade complications (21% vs 24%, P = 0.22). A more recent RC era and ileal conduit diversion were associated with receiving an ICUD. Higher BMI, ASA score ≥3, and receiving a neobladder were associated with longer operating times. Shorter operating time was associated with male gender, older age, ICUD, and centres with a larger annual average RC volume. Longer intensive care unit stay was associated with 90-day high-grade complications. Higher CCI score, prior radiation therapy, neoadjuvant chemotherapy, and ICUD were associated with a higher risk of 90-day readmissions.
Utilisation of ICUD has increased over the past decade. ICUD was associated with more overall complications and readmissions compared to ECUD, but not high-grade complications.
比较机器人辅助根治性膀胱切除术(RARC)后腔内(ICUD)与体外(ECUD)尿流改道的围手术期结果。
我们回顾性地分析了国际机器人膀胱切除术协会(IRCC)的前瞻性数据库。共纳入了 28 家机构的 972 名接受 RARC 的患者。采用倾向评分匹配法,根据年龄、性别、体重指数(BMI)、美国麻醉医师协会评分(ASA)、Charlson 合并症指数(CCI)、既往放疗和腹部手术史、新辅助化疗和临床分期,对患者进行匹配。比较匹配组。采用多元逐步逻辑回归和线性回归模型,评估与接受 ICUD、手术时间、90 天高级别并发症(Clavien-Dindo 分级≥III 级)和 RARC 后 90 天再入院相关的变量。
2005 年至 2018 年,ICUD 的使用率从 0%增加到 95%。ICUD 患者的总并发症发生率(66% vs. 58%,P=0.01)和再入院率(27% vs. 17%,P=0.01)更高,但高级别并发症发生率(21% vs. 24%,P=0.22)无差异。RC 时代更新、回肠导管改道与接受 ICUD 相关。较高的 BMI、ASA 评分≥3 和接受新膀胱与手术时间延长相关。手术时间缩短与男性、年龄较大、ICUD 和每年平均 RC 量较大的中心相关。入住重症监护病房时间延长与 90 天高级别并发症相关。CCI 评分较高、放疗史、新辅助化疗和 ICUD 与 90 天再入院风险增加相关。
在过去十年中,ICUD 的使用率有所增加。与 ECUD 相比,ICUD 与更多的总并发症和再入院相关,但与高级别并发症无关。